Geographic and Social Equity in Population-Wide Genomic Screening - Report - MDSpire

Geographic and Social Equity in Population-Wide Genomic Screening

  • By

  • Kalyani Sonawane

  • Daniel P. Judge

  • Ella Moore

  • Samantha Norman

  • Caitlin G. Allen

  • July 13, 2026

Share

Equity in Geographic and Social Aspects of Widespread Genomic Screening

Background

Genomic screening for hereditary conditions like HBOC, Lynch syndrome, and familial hypercholesterolemia is crucial for early intervention. However, access to such screenings is often inequitable, particularly in rural and socially disadvantaged areas. South Carolina's diverse demographics highlight the need for targeted efforts to ensure equitable access to genomic screening.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • In Our DNA SC aims to enroll at least 100,000 participants for no-cost genomic screening.
  • The program integrates implementation science strategies to evaluate its effectiveness.
  • Efforts are made to ensure representation across urban and rural populations.
  • South Carolina Medicaid expanded coverage for BRCA testing and other genomic assessments in 2019.
  • Low utilization of genetic testing persists among rural and underserved populations.

Clinical Implications

Addressing disparities in healthcare access is essential for maximizing the benefits of genomic testing for at-risk populations.

Conclusion

Continued monitoring and evaluation will be critical to the success of the In Our DNA SC program in engaging diverse communities.

Related Resources & Content

  1. JAMA Network Open, 2023 -- Equity in Population-Wide Genomic Screening
  2. Whole Genome Sequencing in Recurrent Glioblastoma: Issues Surrounding Informed Consent and Data Sharing, 2024
  3. Nature Medicine, 2026 -- Population-scale genomic medicine with the Hong Kong Genome Project
  4. Frontiers in Cardiovascular Medicine, 2026 -- Polygenic Risk Score Translation Across Diverse Populations
  5. Tier 1 Genomics Applications and their Importance to Public Health | CDC
  6. Tier 1 Genomics Applications and their Importance to Public Health | CDC
  7. Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study - PubMed
  8. Cascade Genetic Testing Among Relatives at Risk for Lynch Syndrome: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content